While stem cells from bone marrow have become an established therapy for a handful of blood cancers - and while there are high hopes that the cells will someday lead to other major medical advances - critics say entrepreneurs are treating patients with little or no evidence that what they do is effective. George Daley, professor of biological chemistry and molecular pharmacology at Boston Children’s Hospital, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?